Search research articles
Contact Us
Filters
Showing results (1511-1520 of 1,669) with videos related to
Page
of 167
Sort By:
The Journal of Clinical Investigation
|
July 11, 2017
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
Keehoon Jung, Takahiro Heishi, Omar F Khan, et al.
The Journal of Infection
|
October 4, 2021
A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries
Maria Victoria Humbert, Precious Chinonyerem Opurum, Nathan J Brendish, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 14, 2019
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
A T Shaw, G J Riely, Y-J Bang, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 31, 2020
Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas
Clifton Rodrigues, Thomas Hank, Motaz Qadan, et al.
Cancer Chemotherapy and Pharmacology
|
January 12, 2007
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer
Jeffrey A Meyerhardt, Jeffrey W Clark, Jeffrey G Supko, et al.
Nature Communications
|
November 21, 2025
Estimation of genome-wide coupling in rattlesnake hybrids provides insight into the process of speciation and its progress
Yannick Z Francioli, Justin M Bernstein, Richard H Adams, et al.
Advances in Radiation Oncology
|
July 26, 2017
Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529
Devarati Mitra, Theodore S Hong, Nora Horick, et al.
Cancer Chemotherapy and Pharmacology
|
October 15, 2013
Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma
Lipika Goyal, Jeffrey G Supko, Jordan Berlin, et al.
Cancer Discovery
|
October 4, 2015
Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer
Eunice L Kwak, Leanne G Ahronian, Giulia Siravegna, et al.
Journal of the American College of Surgeons
|
February 2, 2023
Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Nonmetastatic Pancreatic Adenocarcinoma: Intent-to-Treat Analysis
Zhi Ven Fong, Fidel Lopez Verdugo, Carlos Fernandez-Del Castillo, et al.
Page
of 167
Search research articles
Search
Showing results (1511-1520 of 1,669) with videos related to
Sort By:
Page
of 167
The Journal of Clinical Investigation
|
July 11, 2017
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
Keehoon Jung, Takahiro Heishi, Omar F Khan, et al.
The Journal of Infection
|
October 4, 2021
A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries
Maria Victoria Humbert, Precious Chinonyerem Opurum, Nathan J Brendish, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 14, 2019
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
A T Shaw, G J Riely, Y-J Bang, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 31, 2020
Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas
Clifton Rodrigues, Thomas Hank, Motaz Qadan, et al.
Cancer Chemotherapy and Pharmacology
|
January 12, 2007
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer
Jeffrey A Meyerhardt, Jeffrey W Clark, Jeffrey G Supko, et al.
Nature Communications
|
November 21, 2025
Estimation of genome-wide coupling in rattlesnake hybrids provides insight into the process of speciation and its progress
Yannick Z Francioli, Justin M Bernstein, Richard H Adams, et al.
Advances in Radiation Oncology
|
July 26, 2017
Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529
Devarati Mitra, Theodore S Hong, Nora Horick, et al.
Cancer Chemotherapy and Pharmacology
|
October 15, 2013
Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma
Lipika Goyal, Jeffrey G Supko, Jordan Berlin, et al.
Cancer Discovery
|
October 4, 2015
Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer
Eunice L Kwak, Leanne G Ahronian, Giulia Siravegna, et al.
Journal of the American College of Surgeons
|
February 2, 2023
Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Nonmetastatic Pancreatic Adenocarcinoma: Intent-to-Treat Analysis
Zhi Ven Fong, Fidel Lopez Verdugo, Carlos Fernandez-Del Castillo, et al.
Page
of 167